Q1 2021 Syros Pharmaceuticals Inc Earnings Call Transcript
Good morning, and welcome to Syros Pharmaceuticals First Quarter 2021 Financial Results Conference Call. (Operator Instructions) Please be advised that today's call is being recorded.
At this time, I would like to turn the call over to Naomi Aoki, Vice President of Corporate Communications and Investor Relations at Syros.
Thank you. This morning, we issued a press release with our first quarter 2021 financial results, along with anticipated future milestones and recent accomplishments. This release is available on the Investors and Media section of Syros' website at www.syros.com. We will begin the call with prepared remarks by Dr. Nancy Simonian, our Chief Executive Officer; and Joe Ferra, our Chief Financial Officer. We'll then open the call for questions. Dr. David Roth, our Chief Medical Officer; and Dr. Eric Olson, our Chief Scientific Officer, are also on the call and will be available for Q&A.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |